购物车
- 全部删除
- 您的购物车当前为空
Astragaloside 是黄芪中的主要活性成分之一。
为众多的药物研发团队赋能,
让新药发现更简单!
Astragaloside 是黄芪中的主要活性成分之一。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
5 mg | ¥ 108 | 现货 | |
10 mg | ¥ 140 | 现货 | |
25 mg | 询价 | 现货 | |
50 mg | 询价 | 现货 | |
1 mL x 10 mM (in DMSO) | ¥ 218 | 期货 |
产品描述 | Astragaloside, one of the main active ingredients in Astragalus membranaceus. |
体外活性 | Astragaloside IV(10、20、40 ng/mL)抑制非小细胞肺癌(NSCLC)细胞增殖,而低浓度的Astragaloside IV(1、2.5、5 ng/mL)对细胞活性无明显的细胞毒性。此外,Astragaloside IV的联合治疗显著提高了NSCLC细胞对顺铂的化疗敏感性。在分子水平上,Astragaloside IV联合顺铂治疗显著抑制了B7-H3的mRNA和蛋白质水平。Astragaloside IV抑制MDA-MB-231乳腺癌细胞的活力和侵袭能力,抑制有丝分裂原激活蛋白激酶(MAPK)家族成员ERK1/2和JNK的激活,并下调基质金属蛋白酶(MMP)-2和-9的表达。 |
体内活性 | Astragaloside IV(10, 20 mg/kg,口服)显示出强大的能力,预防由短暂脑缺血及再灌注引起的认知缺陷。Astragaloside IV(10mg/kg)和Astragaloside IV(20mg/kg)能显著降低相较于模型组这些细胞因子的水平。Astragaloside IV显著抑制TLR4及其下游蛋白的水平,表明MyD88依赖和独立途径在Astragaloside IV的抗炎效应中扮演重要角色。Astragaloside IV减轻NLRP3与裂解的caspase-1表达,并降低Iba1蛋白表达[1]。在小鼠模型中,高剂量的Astragaloside IV组在48小时存活率上显著提高[60%(9/15)对比13.3%(2/15),P<0.05],血清ALT和AST水平显著下降(P<0.01),肝脏组织病理学指数和肝细胞凋亡程度显著降低(P<0.01),以及肝匀浆中MDA含量显著减少(P<0.01)和SOD活性显著增加。 |
激酶实验 | Briefly, MDA-MB-231 cells treated as indicated or tumor tissues are harvested and lysed in Mg2+ lysis buffer containing 50 mM Tris (pH 7.5), 10 mM MgCl2, 0.5 M NaCl, and protease inhibitor cocktail. Equal amounts of lysates are incubated with PAK-PBD beads at 4°C for 1 h. PAK-PBD beads are pelleted by centrifugation and washed with ish buffer containing 25 mM Tris (pH 7.5), 30 mM MgCl2, 40 mM NaCl. Active Rac1 is detected by western blotting. |
细胞实验 | Cell viability is determined by CCK-8 assay. To be brief, cultured NSCLC cells are seeded into 96-well plates at the density of 4×104 (cells/well). Then 10 μL?well CCK8 solution is added and incubated in dark at 37°C for another 2 h. The absorbance is determined with the wavelength of 490 nm. |
动物实验 | Transient cerebral ischemia and reperfusion is prepared by BCCAO, as BCCAO is considered an ideal model to study transient cerebral ischemia and reperfusion injury-mediated inflammatory response. Mice are randomLy divided into the Sham, Model, Astragaloside IV (10 mg/kg) and Astragaloside IV (20 mg/kg) treatment groups. The Astragaloside IV treatment groups are intragastrically administered 7 days before the surgery and terminated on the day of sacrifice. On the day of the surgery, Astragaloside IV is administrated 2 h prior to ischemia. The Sham-operated and Model groups are treated with distilled water. After the mice are anesthetized with an intraperitoneal injection of chloral hydrate (350 mg/kg), the bilateral common carotid arteries are exposed and carefully separated with a small ventral neck incision and occluded twice (20 min each) with ligated surgical silk as described previously with minor modifications. There is a 10 min reperfusion period between the two occlusion periods (ischemia 20 min ? reperfusion 10 min ? ischemia 20 min). Sham-operated mice are subjected to the same surgical operation without the surgical silk ligation. Mouse body temperature is maintained at 37±0.5°C during the surgery with heating equipment until recovery from the anesthesia. |
别名 | 黄芪总皂苷 |
存储 | keep away from direct sunlight | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
溶解度信息 | DMSO: 50 mg/mL (78.06 mM), Sonication is recommended. |
版权所有©2015-2024 TargetMol Chemicals Inc.保留所有权利.
评论内容